Also trades as: EPIGRAL.BO (BSE) · $vol 0M
EPIGRAL.NS NSE
Epigral Limited
1W: -8.3%
1M: -20.8%
3M: -3.9%
YTD: -5.6%
1Y: -47.3%
₹1,017.00 ($10.56)
+34.80 (+3.54%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$25.0B
-2.1% ▼
5Y CAGR: +24.8%
Gross Profit
$4.6B
-56.6% ▼
5Y CAGR: +2.3%
Operating Income
$3.8B
-59.9% ▼
5Y CAGR: +15.2%
Net Income
$3.3B
-7.2% ▼
5Y CAGR: +26.9%
EPS (Diluted)
$76.95
-9.1% ▼
5Y CAGR: +34.8%
EBITDA
$5.5B
-22.6% ▼
5Y CAGR: +15.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $15.5B | $21.7B | $18.9B | $25.5B | $25.0B |
| YoY Growth | +87.6% | +40.0% | -12.7% | +34.7% | -2.1% |
| Cost of Revenue | $8.0B | $15.3B | $11.2B | $14.8B | $20.4B |
| Gross Profit | $7.5B | $6.4B | $7.8B | $10.7B | $4.6B |
| Gross Margin | 48.3% | 29.6% | 41.1% | 41.8% | 18.5% |
| R&D Expenses | $8M | $8M | $9M | $6M | $0 |
| SG&A Expenses | $217M | $356M | $327M | $501M | $328M |
| Operating Expenses | $3.2B | $744M | $1.0B | $1.1B | $808M |
| Operating Income | $4.2B | $5.7B | $3.3B | $9.5B | $3.8B |
| Operating Margin | 27.3% | 26.2% | 17.6% | 37.3% | 15.3% |
| Interest Expense | $478M | $667M | $741M | $533M | $474M |
| Income Before Tax | $3.8B | $5.2B | $2.9B | $5.4B | $3.4B |
| Tax Expense | $1.3B | $1.7B | $949M | $1.8B | $88M |
| Net Income | $2.5B | $3.5B | $2.0B | $3.6B | $3.3B |
| Net Margin | 16.3% | 16.3% | 10.3% | 14.0% | 13.3% |
| EPS (Diluted) | $60.84 | $85.03 | $47.14 | $84.68 | $76.95 |
| EBITDA | $5.0B | $6.8B | $4.8B | $7.1B | $5.5B |
| Shares Outstanding | 42M | 42M | 42M | 42M | 43M |